Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Engage Grants Program

University of Toronto

$25,000.00

Pilot Study: Creating Antibody-Drug Linkages

FY 2013-14

Summary
AvidBiologics is interested in developing products that direct anti-cancer drugs specifically to target cancer cells in tumors. In doing so, they have acquired a collection of antibody proteins that have been shown to bind to malignant tumors. The proposed research at the University of Toronto will develop ways to attach drugs chemically to those antibodies, so that the drug can be guided specifically to the desired site of action. The project involves designing the chemicals to be used as connecting reagents, producing the desired chemicals, and then developing a process for attaching anti-cancer drugs. The resulting drug-linked reagents will then be tested for their ability to react specifically with the cell-targeting antibodies and the successfully produced materials will be evaluated by AvidBiologics. This is an introductory study to determine the feasibility of the approach and to establish a collaborative effort should the results obtained justify further work.
Program
Engage Grants Program
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
446723-2013
Name nom
Kluger, Ronald
Department département
Chemistry (St. George Campus)
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2013
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
3705
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Bio-organic chemistry
Research subject fr
Chimie bio-organique
Partie
1
Nb partie
1
Application title
Pilot Study: Creating Antibody-Drug Linkages
Keyword
NSERC
Application summary
AvidBiologics is interested in developing products that direct anti-cancer drugs specifically to target cancer cells in tumors. In doing so, they have acquired a collection of antibody proteins that have been shown to bind to malignant tumors. The proposed research at the University of Toronto will develop ways to attach drugs chemically to those antibodies, so that the drug can be guided specifically to the desired site of action. The project involves designing the chemicals to be used as connecting reagents, producing the desired chemicals, and then developing a process for attaching anti-cancer drugs. The resulting drug-linked reagents will then be tested for their ability to react specifically with the cell-targeting antibodies and the successfully produced materials will be evaluated by AvidBiologics. This is an introductory study to determine the feasibility of the approach and to establish a collaborative effort should the results obtained justify further work.